Trial Profile
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2011
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms SFBRI
- 10 Dec 2005 New trial record.